Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer (Q29616112)
Jump to navigation
Jump to search
scientific article (publication date: 20 October 2005)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer |
scientific article (publication date: 20 October 2005) |
Statements
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer (English)
2 references
Daniel W Visscher
Edith A Perez
Vera J Suman
Wilma L Lingle
James N Ingle
Eleftherios P Mamounas
Edward H Romond
John Bryant
Charles E Geyer
Nancy E Davidson
Elizabeth Tan-Chiu
Silvana Martino
Soonmyung Paik
Peter A Kaufman
Thomas M Pisansky
Louis Fehrenbacher
Leila A Kutteh
Victor G Vogel
Robert B Jenkins
Ann M Brown
Shaker R Dakhil
Pamela M Klein
Norman Wolmark
1 October 2005
2 references
353
2 references
16
2 references
Identifiers
3 references
3 references